Effects of insulinlike growth factor binding proteins on insulinlike growth factor-I biodistribution in tumor-bearing nude mice

Journal of Nuclear Medicine

Volumn 41, Issue 2, 2000, Pages 318-326

  Sun, Bao Fu ^a   Kobayashi, Hisataka ^a   Le, Nhat ^a   Yoo, Tae M ^a   Drumm, Debra ^a   Paik, Chang H ^a   McAfee, John G ^a   Carrasquillo, Jorge A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endocytosis; Growth factor receptor; Insulinlike growth factor binding proteins; Insulinlike growth factor I

Indexed keywords

IODINE 125; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TOSYLCHLORAMIDE SODIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RADIOACTIVITY; RADIOIODINATION; RADIOISOTOPE DISTRIBUTION; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RATS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0033973809     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrinol Rev. 1989;10:68-91.
2. LeRoith D, Roberts CT Jr. Insulin-like growth factors and their receptors in normal physiology and pathological states. J Pediatr Endocrinol. 1993;6:251-255.
3. Hana V, Murphy LJ. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line. Endocrinology. 1994;135:2511-2516.
4. Fleming MG, Howe SF, Graf LH Jr. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas. Am J Dermatopathol. 1994;16:383-391.
5. Lowe WL Jr. Biological actions of the insulin-like growth factors. In: LeRoith D, ed. Insulin-like Growth Factors: Molecular and Cellular Aspects. Boca Raton, FL: CRC; 1991:49-85.
6. Teruel T, Valverde AM, Alvarez A, Benito M, Lorenzo M. Differentiation of rat brown adipocytes during late foetal development: role of insulin-like growth factor I. Biochem J. 1995;310:771-776.
7. Hernandez-Sanchez C, Lopez-Carranza A, Alarcon C, de La Rosa EJ, de Pablo F. Autocrine/paracrine role of insulin-related growth factors in neurogenesis: local expression and effects on cell proliferation and differentiation in retina. Proc Natl Acad Sci USA. 1995;92:9834-9838.
8. Birnbaum RS, Bowsher RR, Wiren KM. Changes in IGF-I and -II expression and secretion during the proliferation and differentiation of normal rat osteoblasts. J Endocrinol. 1995;144:251-259.
9. Pretzer D, Ghaida JA, Rune GM. Growth factors (EGF, IGF-1) modulate the morphological differentiation of adult marmoset (Callithrix jacchus) Sertoli cells in vitro. J Androl. 1994;15:398-409.
10. Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A. Insulin-like growth factors activate estrogen receptors to control the growth and differentiation of the human neuroblastoma cell line SK-ER3. Mol Endocrinol. 1994;8:910-918.
11. Favoni RE, de Cupis A, Ravera F, et al. Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. Int J Cancer. 1994;56:858-866.
12. Singh P, Rubin N. Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology. 1993;105:1218-1237.
13. Yballe CM, Vu TH, Hoffman AR. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. J Clin Endocrinol Metab. 1996;81:1607-1612.
14. LeRoith D, Werner H, Neuenschwander S, Kalebic T, Helman LJ. The role of the insulin-like growth factor-I receptor in cancer. Ann N Y Acad Sci. 1995;766:402-408.
15. Moody TW, Cultitta F. Growth factor and peptide receptors in small cell lung cancer. Life Sci. 1993;52:1161-1173.
16. Quinn KA, Treston AM, Unsworth EJ, et al. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem. 1996;271:11477-11483
17. Nakahashi K, Kitahori Y, Konishi N, Ohnishi T, Sugimura M, Hiasa Y. Establishment of a rat thyroid carcinoma cell line in vitro demonstrating high DNA synthesis in response to insulin-like growth factor I. Cancer Lett. 1996;101:247-255.
18. Shimasaki S, Shimonaka M, Zhang HP, Ling N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem. 1991;266:10646-10653.
19. Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm. 1993;47:1-114.
20. Sheikh MS, Shao ZM, Clemmons DR, LeRoith D, Roberts CT Jr, Fontana JA. Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biochem Biophys Res Commun. 1992;183: 1003-1010.
21. Shemer J, Yaron A, Werner H, et al. Regulation of insulin-like growth factor (IGF) binding protein-5 in the T47D human breast carcinoma cell line by IGF-I and retinoic acid. J Clin Endocrinol Metab. 1993;77:1246-1250.
22. Sheikh MS, Shao ZM, Hussain A, et al. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol. 1993;155:556-567.
23. Shao ZM, Sheikh MS, Ordonez JV, et al. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res. 1992;52:5100-5103.
24. 125I-labeled des(1-3)IGF-I in tumor-bearing nude mice and its in vitro catabolism. Cancer Res. 1997;57:2754-2759.
25. Blakesley VA, Kalebic T, Helman LJ, et al. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors: the role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. Endocrinology. 1996;137:410-417.
26. Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Ann Biochem. 1980;107:220-239.
27. Szabo L, Mottershead DG, Ballard FJ, Wallace JC. The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-I for binding. Biochem Biophys Res Commun. 1988;151:207-214.
28. Ross M, Francis GL, Szabo L, Wallace JC, Ballard FJ. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-2 but not des-(1-3). Biochem J. 1989;258:267-272.
29. Ballard FJ, Knowles SE, Walton PE, et al. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. J Endocrinol. 1991;128:197-204.
30. Lord APD, Martin AA, Ballard FJ, Read LC. Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins. J Endocrinol 1994;141:505-515.
31. Cardin AD, Weintraub HJ. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 1989;9:21-32.
32. Clemmons DR, Underwood LE, Chatelain PG, Van Wyk JJ. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin. J Clin Endocrinol Metab. 1983;56:384-389.
33. Arai T, Clarke J, Parker A, Busby W Jr, Nam T, Clemmons DR. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin. J Biol Chem. 1996;271:6099-6106.
34. Baxter RC. Glycosaminoglycans inhibit formation of the 140-kDa insulin-like growth factor-binding protein complex. Biochem J. 1990;271:773-777.
35. Arai T, Busby W Jr, Clemmons DR. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology. 1996;137:4571-4575.
36. Booth BA, Boes M, Bar RS. IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. Am J Physiol. 1996;271:465-470.
37. Arai T, Parker A, Busby W Jr, Clemmons DR. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. J Biol Chem. 1994;269: 20388-20393.
38. Lord APD, Bastian SEP, Read LC, Walton PE, Ballard FJ. Differences in the association of insulin-like growth factor-I (IGF-I) and IGF-I variants with rat, sheep, pig, human and chicken plasma-binding proteins. J Endocrinol. 1994;140: 475-482.
39. Prager D, Li HL, Yamasaki H, Melmed S. Human insulin-like growth factor I receptor internalization: role of the juxtamembrane domain. J Biol Chem. 1994;269:11934-11937.
40. Zapf A, Hsu D, Olefsky JM. Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts. Endocrinology. 1994;134:2445-2452.